MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Human Vaccines & Immunotherapeutics
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

399 results · 1 filter active ·
Results by year
20112025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
399 works in the cohort · of 4,299,418page 4 of 8

Labels cover 1 of 399 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 399 of 399 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Update on oral immunotherapy for egg allergy
François Graham, Natacha Tardio, Louis Paradis, Anne Des Roches, Philippe Bégin
2017· review· en· Human Vaccines & Immunotherapeutics· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
afffundunlabeled
On the benefits of sin
Matthew S. Parsons, Sybille Müller, Heinz Köhler, Michael D. Grant, Nicole F. Bernard
2013· review· en· Human Vaccines & Immunotherapeutics· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
17
citations
affunlabeled
Drug allergy
Richard Warrington
2012· review· en· Human Vaccines & Immunotherapeutics· Medicine
machine prediction:candidate · noneconsensus · none
16
citations
affunlabeled
Hypothesis driven development of new adjuvants
Jessica C. Dong, Gary Kobinger
2013· review· en· Human Vaccines & Immunotherapeutics· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
16
citations
affunlabeled
Pertussis models to inform vaccine policy
Patricia T. Campbell, James M. McCaw, Jodie McVernon
2015· review· en· Human Vaccines & Immunotherapeutics· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affunlabeled
Antibody therapy for Ebola
Xiangguo Qiu, Gary Wong
2014· article· en· Human Vaccines & Immunotherapeutics· Medicine
machine prediction:candidate · noneconsensus · none
15
citations
affunlabeled
The cost effectiveness of rotavirus vaccination in Iran
Yasaman Mousavi Jarrahi, Seyed Mohsen Zahraei, Nader Sadigh, Keyhan Esmaeelpoor Langeroudy, Mahmoud Khodadost, Mehdi Ranjbaran +3 more
2015· article· en· Human Vaccines & Immunotherapeutics· Medicine
machine prediction:candidate · noneconsensus · none
14
citations

How this was built: Screen · Findings · About